The tiny zebrafish is helping researchers rapidly determine whether a newborn’s genetic mutation is likely to cause spinal muscular atrophy (SMA), one of the leading causes of infant mortality worldwide. The world-first research, led by Dr. Jean Giacomotto from Griffith University’s Institute for Biomedicine and Glycomics, is featured on the front cover of EMBO Molecular Medicine. The research is titled “Clinical relevance of zebrafish for gene variants testing: Proof-of-principle with SMN1/SMA.”
This article was originally published on MedicalXpress.com
